Group items tagged

The Damon Runyon-Rachleff Innovation Award is designed to provide support for the next generation of exceptionally creative thinkers with "high-risk/high-reward" ideas that have the potential to significantly impact our understanding of and/or approaches to the prevention, diagnosis or treatment of cancer. The Innovation Award is specifically designed to provide funding to extraordinary early career researchers who have an innovative new idea but lack sufficient preliminary data to obtain traditional funding. It is not designed to fund incremental advances. The research supported by the award must be novel, exceptionally creative and, if successful, have the strong potential for high impact in the cancer field. Awards are made to institutions for support of the Damon Runyon-Rachleff Innovation Investigators. All awards are approved by the Board of Directors of the Damon Runyon Cancer Research Foundation acting upon the recommendation of the Innovation Award Committee.

The Damon Runyon-Rachleff Innovation Award is designed to provide support for the next generation of exceptionally creative thinkers with "high-risk/high-reward" ideas that have the potential to significantly impact our understanding of and/or approaches to the prevention, diagnosis or treatment of cancer. The Innovation Award is specifically designed to provide funding to extraordinary early career researchers who have an innovative new idea but lack sufficient preliminary data to obtain traditional funding. It is not designed to fund incremental advances. The research supported by the award must be novel, exceptionally creative and, if successful, have the strong potential for high impact in the cancer field. Awards are made to institutions for support of the Damon Runyon-Rachleff Innovation Investigators. All awards are approved by the Board of Directors of the Damon Runyon Cancer Research Foundation acting upon the recommendation of the Innovation Award Committee.

The goal of this FOA is to enhance the diversity of the drug abuse research workforce by providing dissertation awards on topics related to the study of basic and clinical neuroscience, development, epidemiology, prevention, treatment, services, or women and sex/gender differences as they relate to drug abuse. This support will enhance the pool of highly talented drug abuse scientists who conduct research within the funding priority areas (http://www.drugabuse.gov/funding/funding-priorities) or in the NIDA strategic plan (https://www.drugabuse.gov/about-nida/2016-2020-nida-strategic-plan). Applications are encouraged from doctoral candidates in a variety of academic disciplines and programs. This program will ultimately facilitate the entry of promising new investigators into the field of drug abuse research and promote transdisciplinary collaborations. This award is for up to two years of support for the completion of the doctoral dissertation research project.

The goal of this FOA is to enhance the diversity of the drug abuse research workforce by providing dissertation awards on topics related to the study of basic and clinical neuroscience, development, epidemiology, prevention, treatment, services, or women and sex/gender differences as they relate to drug abuse. This support will enhance the pool of highly talented drug abuse scientists who conduct research within the funding priority areas (http://www.drugabuse.gov/funding/funding-priorities) or in the NIDA strategic plan (https://www.drugabuse.gov/about-nida/2016-2020-nida-strategic-plan). Applications are encouraged from doctoral candidates in a variety of academic disciplines and programs. This program will ultimately facilitate the entry of promising new investigators into the field of drug abuse research and promote transdisciplinary collaborations. This award is for up to two years of support for the completion of the doctoral dissertation research project.

This Funding Opportunity Announcement (FOA) invites an application from the Program Directors/Principal Investigators of the Coordination and Evaluation Center (CEC), which is currently supporting the research being performed for the Enhancing the Diversity of the NIH-Funded Workforce Program. This program, known as the Diversity Program Consortium (DPC), consists of three integrated initiatives: Building Infrastructure Leading to Diversity (BUILD), the National Research Mentoring Network (NRMN) and the CEC. The CEC will continue to organize the activities required for the attainment of program-wide goals and to measure the agreed upon hallmarks of success at the student, faculty, and institutional level. The CEC will employ and refine the processes developed in the previous funding period to assess the impact of BUILD and NRMN activities on attainment of the hallmarks. The CEC will coordinate the collection of data from the DPC, assess the data in an ongoing way, provide feedback, and facilitate an iterative process of program adjustment to maximize the research of BUILD and NRMN. The CEC should also focus on the dissemination of effective strategies for enhancing the diversity of the biomedical research workforce and for transitioning into a sustainable model for evaluating diversity enhancing programs beyond the funding cycle.

This Funding Opportunity Announcement (FOA) invites an application from the Program Directors/Principal Investigators of the Coordination and Evaluation Center (CEC), which is currently supporting the research being performed for the Enhancing the Diversity of the NIH-Funded Workforce Program. This program, known as the Diversity Program Consortium (DPC), consists of three integrated initiatives: Building Infrastructure Leading to Diversity (BUILD), the National Research Mentoring Network (NRMN) and the CEC. The CEC will continue to organize the activities required for the attainment of program-wide goals and to measure the agreed upon hallmarks of success at the student, faculty, and institutional level. The CEC will employ and refine the processes developed in the previous funding period to assess the impact of BUILD and NRMN activities on attainment of the hallmarks. The CEC will coordinate the collection of data from the DPC, assess the data in an ongoing way, provide feedback, and facilitate an iterative process of program adjustment to maximize the research of BUILD and NRMN. The CEC should also focus on the dissemination of effective strategies for enhancing the diversity of the biomedical research workforce and for transitioning into a sustainable model beyond the funding cycle.

This award provides funding support for experienced researchers with recognized productivity - either within or outside the eczema field - to conduct highly innovative, cutting-edge investigations related to eczema. Data from this award can then be used to seek additional, larger-scale funding from the National Institutes of Health (NIH) or other funding entities to build on these discoveries. Eczema Champion Research Grants facilitate trail-blazing research by established investigators who have built a life-long career in eczema research, as well as thought leaders from other areas of study that can bring additional new perspectives to the research forefront. This award also serves as a bridge for previous successful NEA Catalyst Research Award recipients by providing a funding mechanism to stay in the eczema research field and strengthen their research program and commitment to advancing our understanding of this serious disease. Proposals should address at least one of the following research priorities: Cutting Edge Basic & Translational Science* Eczema Heterogeneity: Novel Insights Innovations in Clinical Practice & Care Understanding & Alleviating Disease Burden Eczema Prevention

This NIH Funding Opportunity Announcement (FOA), supported by funds from the NIH Common Fund (Common Fund), invites applications to support bioinformatics research training programs at low or middle income (LMIC) African country institutions with significant genomics research capacity.  African applicants may propose graduate degree and long term postdoctoral bioinformatics research training in collaboration with other African or high income country (HIC) collaborators.  It is expected that these training programs will address the need for bioinformatics research expertise in the H3Africa Consortium and result in sustainable centers of bioinformatics research training relevant to global health research for the African continent.

This administrative supplement funding opportunity is part of the Common Fund Metabolomics Program created to increase and improve the nation's ability to undertake metabolomics analyses in translational and clinical research. Metabolomics has great potential to advance our understanding of human diseases, but requires specialized expertise in metabolomics study design, technology, and data analysis and interpretation. This FOA supports supplemental funds to current NIH-funded research projects for new interactive collaborations between basic or clinical researchers and metabolomics experts to add biomedical studies requiring a metabolomics approach. In addition to enhancing the parent grant by adding metabolomics analyses, collaborative projects must include activities to increase the expertise of the biomedical research group in key aspects of metabolomics study design, analysis, and data interpretation.

The National Marine Fisheries Service (hereinafter, "NMFS") is responsible for the stewardship, conservation, and management of pinniped species in Alaska, including the Steller sea lion, Northern fur seal, ringed seal, bearded seal, spotted seal, ribbon seal, and harbor seal. Two of these pinnipeds are currently listed under the Endangered Species Act: the endangered western Distinct Population Segment (DPS) of Steller sea lions and the threatened Arctic subspecies of ringed seals (a third species, the Beringia DPS of bearded seals, was also listed as threatened but the listing was vacated by the U.S. District Court for the District of Alaska). NMFS has the responsibility to foster the recovery of these ESA-listed species and research is necessary to support our recovery programs for these species. Non-ESA-listed pinniped species or populations in Alaska are listed as strategic stocks under the Marine Mammal Protection Act, and/or are important as a subsistence resource to Alaska Natives and co-managed by NMFS and Alaska Native co-management partners. Research is also an important component to co-management of these animals. Beginning in fiscal year (hereinafter, "FY") 2015, certain priority pinniped research in Alaska will be administered through a competitively-funded, merit-based grants program. This program concerns only Alaskan pinnipeds for which NMFS bears responsibility; proposals focusing on marine mammals under the jurisdiction of the U.S. Fish and Wildlife Service will not be considered for funding under this grant program. This document describes how to prepare and submit proposals for funding in FY 2015 and how NMFS will determine which proposals will be funded.

The Fund recognizes that young investigators may find it difficult to remain in pediatric research because of a lack of funding. Therefore, the purpose of this program is to encourage the development of medical research in child health by awarding small grants to new researchers, helping them gain a foothold in this important area. The Fund will make up to 30 awards total with two funding cycles (15 awards each).

The National Institute of General Medical Sciences (NIGMS) announces the availability of funds for Administrative Supplements to NIGMS-funded R01, R37, P01, and U01 grants.  These funds are intended for the purchase of single pieces of equipment whose requested direct costs are between $50,000 and $250,000. Equipment in this price range is often difficult to purchase under the parent grant.  Two or more NIGMS grantees at the same institution with similar equipment needs are encouraged to submit separate requests (each between $50,000 and $250,000) that cross-reference each other.  It is expected that the amount of funds requested for such joint purchases will reflect the actual proportion of the time that the shared equipment would be used by each PI.  NIGMS encourages requests that reflect institutional commitment.

The National Institute of General Medical Sciences (NIGMS) announces the availability of funds for Administrative Supplements to NIGMS-funded T32 Predoctoral Institutional National Research Service Awards (NRSA). These funds are designed to provide support for the implementation and assessment of innovative, novel curricular and training activities aimed at the development of skills needed to be a competitive biomedical research scientist. The funds are designed to promote the reworking and revitalization of biomedical predoctoral research education and training

This fall, NSF intends to announce Mid-scale RI funding opportunities. These will be for research infrastructure that will advance the frontiers of discovery in any of the research domains supported by NSF.2 These forthcoming funding opportunities are intended to encompass research infrastructure broadly defined, from the creation of mid-scale disciplinary instrumentation to the implementation (including acquisition and construction) of mid-scale facilities, cyberinfrastructure and other infrastructure that are demonstrated to be necessary to support specific science, engineering or education research objectives associated with current or future NSF-supported research activities. This portfolio may also include mid-scale upgrades to existing research infrastructure. NSF anticipates that one solicitation will include an opportunity to propose Mid-scale RI projects with a total project cost of between approximately $6 million and approximately $20 million, pending the availability of funds. A second solicitation is expected to include an opportunity to propose Mid-scale RI projects with a total project cost of between approximately $20 million and approximately $70 million, pending the availability of funds.

The Division of Molecular and Cellular Biosciences (MCB) supports quantitative, mechanistic, predictive, and theory-driven fundamental research designed to promote understanding of complex living systems at the molecular, subcellular, and cellular levels. While recognizing the need for thorough and accurate descriptions of biological complexes and pathways, the priority of the Division is to support work that advances the field by capturing the predictive power of mechanistic, quantitative, and evolutionary approaches. Two funding tracks will be available. Core Program Track proposals are solicited to support research relevant to the four MCB core clusters: o Cellular Dynamics and Function o Genetic Mechanisms o Molecular Biophysics o Systems and Synthetic Biology Rules of Life Track proposals that integrate across the scales in biological sciences are solicited to support research that spans from the molecular and cellular levels normally funded by MCB to organismal and ecosystem scales typically funded by other divisions in the Biological Sciences. This track provides new opportunities to advance our understanding of the Rules of Life by new mechanisms for review and funding of proposals that would not ordinarily fit well within one division in the Biological Sciences Directorate.

This Limited Competition Funding Opportunity Announcement (FOA) invites an application from the currently funded NIH Common Fund-supported Extracellular RNA Communication Consortium (ERCC) Data Management and Resource Repository (DMRR) to support Stage 2 efforts of this program.  The overall programmatic goal of the DMRR is to integrate the efforts of all funded components of the ERCC and serve as a community-wide resource for extracellular RNA (exRNA) standards, protocols, and data. 

Supported by the NIH Common Fund (Common Fund) Science of Behavior Change (SOBC) Program, this Funding Opportunity Announcement (FOA) solicits competitive revision (formerly known as a competitive supplement) applications to NIH-supported clinical trials awarded as research project R34 grants. The goal of the SOBC Program is to advance a mechanisms-focused, experimental medicine approach to behavior change research. Funded projects in the SOBC Research Network (https://commonfund.nih.gov/behaviorchange/fundedresearch) have developed experimental manipulations, assays, and/or measures (hereafter referred to as assays for brevity) to support an experimental medicine approach to behavior change research. The SOBC Measures Repository is accessible from the SOBC Research Network Open Science Framework (OSF) page at https://osf.io/zp7b4. The goal of this FOA is to accelerate the adaptation, validation, and translation of SOBC Research Network assays for use in ongoing clinical trials. This FOA calls for the integration of SOBC Research Network assays into active NIH-supported clinical trials of drugs, devices, procedures, or behavior modifications. As such, the active NIH-supported clinical trial used to respond to this FOA does not have to be a behavior change trial or identify behavior change as a primary outcome. The integration of SOBC Research Network assays into ongoing clinical trials will accelerate the development of interventions and experimental manipulations that have been shown to engage specific mechanisms of behavior change and the development of assays that verify engagement of those behavior change targets.

The TriService Nursing Research Program (TSNRP) was founded in 1992 and funds and supports rigorous scientific research studies and evidence-based practice (EBP) projects in the field of military nursing. TSNRP is located within the Uniformed Services University of the Health Sciences (USU) which is authorized by 10 USC 2113(g)(1)(A) to make grants to any nonprofit entity for the purpose of carrying out cooperative enterprises in medical research, medical consultation, and medical education. TSNRP supports nurse scientists in all stages of their careers through research funding, education, and mentoring. Since its inception, TSNRP has funded over 430 research and EBP projects; 19 applications were successfully funded in Fiscal Year 2016. The mission of TSNRP is to facilitate nursing research to optimize the health of military members and their beneficiaries, with the following the five strategic goals: 1. Advance a culture of scientific inquiry and scholarly knowledge application. 2. Advocate mission critical priorities by building a military nursing research science base. 3. Expand infrastructure to support and develop nursing research and EBP. 4. Invest in military nurse scientists and programs of research. 5. Foster interservice nursing research capacity.

This program seeks to improve the quality and timeliness of forensic science and medical examiner services, including services provided by laboratories operated by States and units of local government. Among other things, funds may be used to eliminate a backlog in the analysis of forensic evidence and to train and employ forensic laboratory personnel, as needed, to eliminate such a backlog. The Coverdell Act requires that 15 percent of program funds be awarded competitively. These competitive funds may be awarded to SAAs or dispersed directly to units of local government based on the merits of the respective applications. This solicitation will fund competitive awards only.

This Funding Opportunity Announcement (FOA) seeks to stimulate HIV/AIDS research within the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) that addresses high priority HIV/AIDS research priorities outlined by the NIH Office of AIDS Research (OAR). These priorities are described in NOT-OD-15-137: NIH HIV/AIDS Research Priorities and Guidelines for Determining AIDS Funding. This Funding Opportunity Announcement (FOA) seeks to stimulate HIV/AIDS research within the mission of the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) that addresses high priority HIV/AIDS research priorities outlined by the NIH Office of AIDS Research (OAR). These priorities are described in NOT-OD-15-137: NIH HIV/AIDS Research Priorities and Guidelines for Determining AIDS Funding.

SFARI is seeking to add additional clinical sites to its existing network for the purposes of recruiting SPARK participants. Selected sites will receive funding on an annual basis for up to three years, subject to periodic performance review. Support for a clinical site will include the following allowable costs: principal investigator salary - up to 10 percent effort for a PI or PI(s); site coordinator(s) salary - up to two full-time coordinators or the equivalent; funds for conducting community outreach in catchment area (excludes direct payment to participants); funds for recruitment and retention materials and supplies such as tablets to assist families with online registration; and, if applicable, funds to support return of genetic and behavioral results.

The National Institute of Dental and Craniofacial Research (NIDCR) intends to continue support for research conducted within a national Dental Practice-Based Research Network (DPBRN). The NIDCR will fund one national DPBRN Administrative and Resource Center (RFA-DE-19-001) and one national DPBRN Coordinating Center (RFA-DE-19-002) as companion awards to support the infrastructure for and implementation of multiple observational studies and clinical trials. This Funding Opportunity Announcement (FOA) is soliciting applications for investigator-initiated clinical observational studies and clinical trials to be conducted in the DPBRN through a milestone-driven UG3/UH3 cooperative agreement mechanism. Each UG3/UH3 award will support an individual project which will utilize the DPBRN infrastructure and resources for study planning and implementation. This FOA supports a UG3 clinical study planning phase and potential transition to a UH3 implementation phase, with a combined total funding period of up to six years. Progression to the UH3 phase is based on an administrative review and is dependent on success in meeting UG3 milestones, consideration of the DPBRN as an appropriate venue for conduct of the research, NIDCR program priorities, and availability of funds. The main goals of the national DPBRN are to streamline the implementation of national oral health research studies in dental practices on topics of importance to practitioners and their patients, to provide evidence useful in daily patient care, and to facilitate the translation of research findings into clinical practice.